TTK inhibitors (NTRC)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTTK inhibitors (NTRC)
Drug Alias NameNTRC-0066-0NTRC-1501-0
ClassificationSmall molecules
Mechanisms of ActionDual specificity protein kinase TTK inhibitorsAnticancer protein kinase inhibitors
TargetsDual specificity protein kinase TTK
Therapy Area/IndicationsMetastatic breast cancerNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrossfire Oncology BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrossfire Oncology BV
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A